See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420565_2023_Rein_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001420565, Rein Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 21,873,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 70,000 |
| 3 | remainder_Assets | 64,000 |
| 4 | LiabilitiesCurrent | 3,384,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,724,722 |
| 9 | ResearchAndDevelopmentExpense | 18,072,101 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 368,729 |
| 13 | remainder_ComprehensiveNetIncome | -27,213 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 22,007,000 |
| 1 | Liabilities | 3,384,000 |
| 2 | Expenses | 27,796,823 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 18,623,000 |
| 5 | NetIncome | -27,428,094 |
| 6 | ComprehensiveNetIncome | -27,441,700 |
| 7 | BaseVar | 26,791,882 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.04 |
| 9 | EconomicCapitalRatio | 2.33 |
Edgar->Model Mapping
Feature Distribution
Change over Time
